Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
55.12
-1.13 (-2.01%)
At close: Nov 13, 2026, 4:00 PM EST
55.13
+0.01 (0.02%)
After-hours: Nov 13, 2026, 6:54 PM EST
Sol-Gel Technologies Market Cap
Sol-Gel Technologies has a market cap or net worth of $180.46 million as of November 13, 2026. It is the 21,007th most valuable company in the world and the 3,591st biggest in the United States. Its market cap has increased by 105.54% in one year.
Market Cap
180.46M
Enterprise Value
136.85M
1-Year Change
105.54%
Global Rank
Country Rank
#3,591 United States
Category
ChartMarket Cap Chart
Since February 1, 2018, Sol-Gel Technologies's market cap has decreased from $228.30M to $180.46M, a decrease of -20.95%. That is a compound annual growth rate of -2.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 180.46M | 53.72% |
| Dec 31, 2025 | 117.40M | 353.28% |
| Dec 31, 2024 | 25.90M | -15.91% |
| Dec 29, 2023 | 30.80M | -70.81% |
| Dec 30, 2022 | 105.50M | -38.34% |
| Dec 31, 2021 | 171.10M | -24.02% |
| Dec 31, 2020 | 225.20M | -35.58% |
| Dec 31, 2019 | 349.60M | 206.94% |
| Dec 31, 2018 | 113.90M | -50.11% |
| Feb 1, 2018 | 228.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NervGen Pharma | 192.47M |
| Cartesian Therapeutics | 190.64M |
| MediWound | 187.35M |
| Pyxis Oncology | 187.19M |
| Korro Bio | 186.94M |
| Entrada Therapeutics | 184.36M |
| Alpha Cognition | 183.26M |
| Whitehawk Therapeutics | 180.57M |